Version 5.4
Interaction: MYC :: CDKN1A XML
Summary
InnateDB Group ID 348731
Short name MYC :: CDKN1A
Full name MYC interacts with CDKN1A
Interaction type physical association
Participants
Participant 1
Molecule: IDBG-35442
Molecule type: protein
Species: Homo sapiens
HUGO: MYC
Full name: v-myc myelocytomatosis viral oncogene homolog (avian)
Direction: input
Biological role: unspecified role
Participant 2
Molecule: IDBG-85033
Molecule type: protein
Species: Homo sapiens
HUGO: CDKN1A
Full name: cyclin-dependent kinase inhibitor 1A (p21, Cip1)
Direction: input
Biological role: unspecified role
Evidence Reference 1
InnateDB ID IDB-2063527.1
Last Modified 2018-01-13
Review status reviewed [Report errors or provide feedback]
Source database INNATEDB
Source database ID IDB-2063527
PMID 15780936
Interaction detection method chromatin immunoprecipitation assay
Host system invitro
Host organism
Cell status cell line
Cell line HCT116
Cell type
Tissue type
Comment Figure 4B.
Participants
Participant Identification Method Experimental Role Participant Accession
1) MYC predetermined participant bait
2) CDKN1A primer specific pcr prey
Evidence Reference 2
InnateDB ID IDB-2063527.1
Last Modified 2018-01-13
Review status reviewed [Report errors or provide feedback]
Source database INNATEDB ALLERGY
Source database ID AAP-2063527
PMID 15780936
Interaction detection method chromatin immunoprecipitation assay
Host system invitro
Host organism
Cell status cell line
Cell line HCT116
Cell type
Tissue type
Comment Figure 4B.
Participants
Participant Identification Method Experimental Role Participant Accession
1) MYC predetermined participant bait
2) CDKN1A primer specific pcr prey

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca